Endoscopy Clinical Trials

Clinical trials related to Endoscopy Procedure

Randomized Controlled Trial Evaluating the Efficacy of CAD in Screening Colonoscopy to Reduce the Risk of Advanced Adenoma at 3 Years.

Status: Recruiting
Location: See all (13) locations...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The occurrence of interval cancers after colonoscopy raises the possibility of missed lesions. High- performance computer aided diagnosis (CAD) systems have been specially designed for the detection of colorectal lesions (CAD for detection is named CADe). The use of CADe improves adenoma detection in screening colonoscopy. The potential of CADe system in reducing the rate of progression to advanced polyps or interval cancer between two colonoscopies remains still uncertain.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients over 18 years of age with indication for colonoscopy as part of a screening program, after a positive immunological (FIT) test, and/or for personal or family history of colorectal cancer and/or personal history of colonic adenomas,

• Written informed consent signed

• Patients covered by a health-care insurance.

Locations
Other Locations
France
CH de la Côte Basque
NOT_YET_RECRUITING
Bayonne
CHU Brest la Cavale Blanche
NOT_YET_RECRUITING
Brest
Clinique Paris Bercy
NOT_YET_RECRUITING
Charenton-le-pont
CHU de Limoges
NOT_YET_RECRUITING
Limoges
Institut Paoli Calmettes
NOT_YET_RECRUITING
Marseille
Clinique Jules Verne
NOT_YET_RECRUITING
Nantes
CHU Nîmes
NOT_YET_RECRUITING
Nîmes
APHP - Hôpital Saint Antoine
NOT_YET_RECRUITING
Paris
Aphp-Hegp
NOT_YET_RECRUITING
Paris
CHU Bordeaux - Hôpital Haut Lévêque
RECRUITING
Pessac
CHU de Rennes
NOT_YET_RECRUITING
Rennes
Clinique Pasteur
NOT_YET_RECRUITING
Toulouse
CHRU de Nancy - Hôpital Brabois Adultes
NOT_YET_RECRUITING
Vandœuvre-lès-nancy
Contact Information
Primary
Arthur BERGER, MD
arthur.berger@chu-bordeaux.fr
+335 57 67 49 31
Time Frame
Start Date: 2026-03-13
Estimated Completion Date: 2031-03
Participants
Target number of participants: 592
Treatments
Placebo_comparator: Standard colonoscopy
Patients will be enrolled after a pre-colonoscopy consultation and risk-assessment for colorectal cancer. The screening colonoscopy will be performed by an investigator. Patients will be randomized in the endoscopy room after confirmed cecal intubation and quality of bowel preparation. Patient has standard colonoscopy
Active_comparator: Colonoscopy with CADe
Patients will be enrolled after a pre-colonoscopy consultation and risk-assessment for colorectal cancer. The screening colonoscopy will be performed by an investigator. Patients will be randomized in the endoscopy room after confirmed cecal intubation and quality of bowel preparation. Patient has colonoscopy with CADe (CAD EYE or GENIUS)
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Bordeaux

This content was sourced from clinicaltrials.gov